SCHEMBL9057622

SCHEMBL9057622

Cc1ccccc1S(=O)(=O)Oc1cc(C(=O)O)cc2c1OC(c1ccccc1)(c1ccccc1)O2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ESR1 P03372 3/20 0.42
ESR2 Q92731 3/20 0.42
GAA P10253 1/20 0.42
POLB P06746 2/20 0.37
ATM Q13315 1/20 0.36
CNR1 P21554 4/20 0.35
RAD52 P43351 1/20 0.34
ALKBH2 Q6NS38 1/20 0.34
ALKBH3 Q96Q83 1/20 0.34
HTR6 P50406 1/20 0.33
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SENP8 Q96LD8 1/20 0.32
SENP7 Q9BQF6 1/20 0.32
SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9058011 0.85 ALKBH2 (0.37) MEN1KMT2APOLBCNR1ALKBH2
SCHEMBL9062926 0.84 KMT2A (0.43) MEN1KMT2APOLBALKBH2ALKBH3
SCHEMBL9062916 0.84 KMT2A (0.43) MEN1KMT2APOLBALKBH2ALKBH3
SCHEMBL9057661 0.83 TYMS (0.38) CYP1A2CYP2C19TDP1L3MBTL1
SCHEMBL9057824 0.82 CNR1 (0.37) POLBCNR1NPC1RAB9ASMN1; SMN2
SCHEMBL9057059 0.82 ALDH1A1 (0.39) MEN1KMT2AGAAPOLBNPC1
SCHEMBL9062931 0.82 PTPN1 (0.39) CYP2C19KMT2ACNR1SMN1; SMN2
SCHEMBL9062967 0.81 ENPP2 (0.44) POLBNPSR1
SCHEMBL9058121 0.81 ITGA1 (0.49)
SCHEMBL9054762 0.80 CNR2 (0.36) MEN1KMT2ACNR1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996008483-A1 GALLIC ACID DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS ROUSSEL UCLAF (FR) 1996-03-21 WO disclosed